Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity‐score matched study
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.932
Abstract: Heart failure oral therapies (HFOTs), including beta‐blockers (BB), renin–angiotensin system inhibitors (RASi) and mineralocorticoid receptor antagonists, administered before hospital discharge after acute heart failure (AHF) might improve outcome. However, concerns have been raised because early… read more here.
Keywords: failure oral; heart; oral therapies; heart failure ... See more keywords
Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes Therapy"
DOI: 10.1007/s13300-021-01051-9
Abstract: Research has shown that glycemic control is associated with lower rates of microvascular and long-term cardiovascular complications. In the analyses reported here, we examined treatment failure on oral glucose-lowering agents (GLAs), defined as having sustained… read more here.
Keywords: failure oral; time failure; treatment; time ... See more keywords
Evidence of Failure of Oral Third-Generation Cephalosporin Treatment for Shigella sonnei Infection.
Sign Up to like & getrecommendations! Published in 2020 at "Open forum infectious diseases"
DOI: 10.1093/ofid/ofaa113
Abstract: In 2017, state health departments notified the Centers for Disease Control and Prevention about 4 patients with shigellosis who experienced persistent illness after treatment with oral third-generation cephalosporins. Given increasing antibiotic resistance among Shigella, these… read more here.
Keywords: failure oral; treatment; third generation; evidence failure ... See more keywords